Personalis Inc. (NASDAQ: PSNL)
$2.04
+0.4250 ( +26.40% ) 1.1M
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Market Data
Open
$2.04
Previous close
$1.61
Volume
1.1M
Market cap
$104.40M
Day range
$1.58 - $2.18
52 week range
$0.89 - $2.43
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 21, 2024 |
| 4 | Insider transactions | 1 | May 21, 2024 |
| 4 | Insider transactions | 1 | May 21, 2024 |
| 4 | Insider transactions | 1 | May 21, 2024 |
| 4 | Insider transactions | 1 | May 21, 2024 |
| 8-k | 8K-related | 13 | May 08, 2024 |
| 10-q | Quarterly Reports | 75 | May 08, 2024 |
| 4 | Insider transactions | 1 | May 02, 2024 |
| ars | Annual reports | 1 | Apr 02, 2024 |
| def | Proxies and info statements | 5 | Apr 02, 2024 |